Gene · 2072
Papers3,434
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,434
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Photodynamic Therapy and Immunological View in Gastrointestinal Tumors. | Cancers (Basel) | 2023 | 38201494 | PubTator, text mining | PubMed |
| PD-L1+ diffuse large B-cell lymphoma with extremely high mutational burden and microsatellite instability due to acquired PMS2 mutation. | Cold Spring Harb Mol Case Stud | 2023 | 38199780 | PubTator, text mining | PubMed |
| The emergence of Fanconi anaemia type S: a phenotypic spectrum of biallelic BRCA1 mutations. | Front Oncol | 2023 | 38146508 | PubTator, text mining | PubMed |
| Identification of Adenovirus E1B-55K Interaction Partners through a Common Binding Motif. | Viruses | 2023 | 38140597 | PubTator, text mining | PubMed |
| Exploring the Potential of Using Marine-Derived Ingredients: From the Extraction to Cutting-Edge Cosmetics. | Mar Drugs | 2023 | 38132941 | PubTator, text mining | PubMed |
| A Novel Arg120Pro Mutation in the RP2 Gene in an Iranian Family with X-linked Retinitis Pigmentosa: A Case Report. | Iran J Med Sci | 2023 | 38094283 | PubTator, text mining | PubMed |
| LINE-1 retrotransposition and its deregulation in cancers: implications for therapeutic opportunities. | Genes Dev | 2023 | 38092519 | PubTator, text mining | PubMed |
| Cellular Responses to Widespread DNA Replication Stress. | Int J Mol Sci | 2023 | 38069223 | PubTator, text mining | PubMed |
| Pan-Cancer Profiling of Intron Retention and Its Clinical Significance in Diagnosis and Prognosis. | Cancers (Basel) | 2023 | 38067392 | PubTator, text mining | PubMed |
| Micro-CT evaluation of the removal of root fillings using rotary and reciprocating systems supplemented by XP-Endo Finisher, the Self-Adjusting File, or Er,Cr:YSGG laser. | Restor Dent Endod | 2023 | 38053777 | PubTator, text mining | PubMed |
| Preserving genome integrity: The vital role of SUMO-targeted ubiquitin ligases. | Cell Insight | 2023 | 38047137 | PubTator, text mining | PubMed |
| Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression. | Brain | 2023 | 38040034 | PubTator, text mining | PubMed |
| Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer. | JCO Precis Oncol | 2023 | 38039432 | PubTator, text mining | PubMed |
| Concepts of multi-level dynamical modelling: understanding mechanisms of squamous cell carcinoma development in Fanconi anemia. | Front Genet | 2023 | 38028610 | PubTator, text mining | PubMed |
| Establishing a novel Fanconi anemia signaling pathway-associated prognostic model and tumor clustering for pediatric acute myeloid leukemia patients. | Open Med (Wars) | 2023 | 38025539 | PubTator, text mining | PubMed |
| Fanconi anemia pathway regulation by FANCI in prostate cancer. | Front Oncol | 2023 | 38023254 | PubTator, text mining | PubMed |
| SNP Array Screening and Long Range PCR-Based Targeted Next Generation Sequencing for Autosomal Recessive Disease with Consanguinity: Insight from a Case of Xeroderma Pigmentosum Group C. | Genes (Basel) | 2023 | 38003022 | PubTator, text mining | PubMed |
| Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma. | Sci Rep | 2023 | 37996508 | PubTator, text mining | PubMed |
| Differential diagnosis of chorea (guidelines of the German Neurological Society). | Neurol Res Pract | 2023 | 37993913 | PubTator, text mining | PubMed |
| Mutation spectrum, expression profiling, and prognosis evaluation of Fanconi anemia signaling pathway genes for 4259 patients with myelodysplastic syndromes or acute myeloid leukemia. | BMC Med Genomics | 2023 | 37974167 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2072/papers?page=9